PT - JOURNAL ARTICLE AU - Yovera-Aldana, Marlon AU - Mezones-Holguín, Edward AU - Agüero-Zamora, Rosa AU - Damas-Casani, Lucy AU - Uriol-Llanos, Becky AU - Espinoza-Morales, Frank AU - Soto-Becerra, Percy AU - Ticse-Aguirre, Ray TI - External validation of Finnish Diabetes Risk Score (FINDRISC) and Latin American FINDRISC for screening of undiagnosed dysglycemia: analysis in a Peruvian hospital health care workers sample AID - 10.1101/2024.02.16.24302929 DP - 2024 Jan 01 TA - medRxiv PG - 2024.02.16.24302929 4099 - http://medrxiv.org/content/early/2024/02/18/2024.02.16.24302929.short 4100 - http://medrxiv.org/content/early/2024/02/18/2024.02.16.24302929.full AB - Aims To evaluate the external validity of Finnish diabetes risk score (FINDRISC) and Latin American FINDRISC (LAFINDRISC) for undiagnosed dysglycemia in hospital health care workers.Methods We carried out a cross-sectional study on health workers without a prior history of diabetes mellitus (DM). Undiagnosed dysglycemia (prediabetes or diabetes mellitus) was defined using fasting glucose and two-hour oral glucose tolerance test. LAFINDRISC is an adapted version of FINDRISC with different waist circumference cut-off points. We calculated the area under the receptor operational characteristic curve (AUROC) and explored the best cut-off point.Results We included 549 participants in the analysis. The frequency of undiagnosed dysglycemia was 17.8%. The AUROC of LAFINDRISC and FINDRISC were 71.5% and 69.2%; p=0.007, respectively. The optimal cut-off for undiagnosed dysglycemiaaccording to Index Youden was ≥ 11 in LAFINDRISC (Sensitivity: 78.6%; Specificity: 51.7%) and ≥12 in FINDRISC (Sensitivity: 70.4%; Specificity: 53.9%)Conclusion The discriminative capacity of both questionnaires is good for the diagnosis of dysglycemia in the healthcare personnel of the María Auxiliadora hospital. The LAFINDRISC presented a small statistical difference, nontheless clinically similar, since there was no difference by age or sex. Further studies in the general population are required to validate these results.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants signed an written informed consent based on the principles of the Declaration of Helsinki. Subjects were free to refuse to participate at any time. The Institutional Ethics Committee for Research of the Universidad Peruana Cayetano Heredia approved the study protocol, under the code CONSTANCIA 382-13-17. We kept the data confidential through codes only the principal investigator had access to the data. We communicate the results to all patients in writing. People with dysglycemia or high LAFINDRISC scores were referred to an endocrinology outpatient clinic.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.